SCHEMBL27486451

SCHEMBL27486451

CCOC(=O)[C@@H](Cc1ccsc1)NC(C)=O

nearest known ligand 0.48

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ TACR1 P25103 4/20 0.48
▸ CTSS P25774 1/20 0.45
▸ CTSK P43235 1/20 0.45
▸ CYP1A2 P05177 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ MME P08473 3/20 0.42
▸ HDAC1 Q13547 2/20 0.41
▸ HDAC6 Q9UBN7 2/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ LMNA P02545 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ KLKB1 P03952 1/20 0.40
▸ TP53 P04637 1/20 0.39
▸ SIRT5 Q9NXA8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6747630 1.00 TACR1 (0.48) TACR1CTSSCTSKCYP1A2CYP2C9
SCHEMBL6190336 0.82 MME (0.54) CTSSCTSKMMEALDH1A1LMNA
SCHEMBL6194235 0.82 MME (0.54) CTSSCTSKMMEALDH1A1LMNA
SCHEMBL242242 0.80 TACR1 (0.71) TACR1CTSSCTSKCYP2C9CYP2C19
SCHEMBL12453492 0.80 TACR1 (0.59) TACR1CTSSCTSKALDH1A1LMNA
SCHEMBL28683018 0.80 CYP1A2 (0.48) CYP1A2CYP2C9CYP2C19MMEALDH1A1
SCHEMBL242241 0.80 TACR1 (0.71) TACR1CTSSCTSKCYP2C9CYP2C19
SCHEMBL25669503 0.80 TACR1 (0.59) TACR1CTSSCTSKALDH1A1LMNA
SCHEMBL8910127 0.79 CYP1A2 (0.50) CYP1A2CYP2C9CYP2C19MMEALDH1A1
Acetyl Tyrosine Ethyl Ester SCHEMBL14370511 0.78 TACR1 (0.58) TACR1MMETSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1202096-C 2-aminothiazoline derivatives and their use as no-synthase inhibitors AVENTIS PHARMA SA (FR) 2005-05-18 — — CN disclosed
CN-1444572-A 2-aminothiazoline derivatives and their use as no-synthase inhibitors AVENTIS PHARMA SA (FR) 2003-09-24 — — CN disclosed
Send feedback